The Pharmacogenetics of OATP1B1 Variants and their impact on the Pharmacokinetics and Efficacy of Elbasvir/Grazoprevir
Year: 2019
Type: article
Source: Pharmacogenomics
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2954997272
